Targeting of MYCN by means of DNA vaccination is effective against neuroblastoma in mice Alexander StermannNicole HuebenerHolger N. Lode Original Article 16 June 2015 Pages: 1215 - 1227
TLR7 tolerance is independent of the type I IFN pathway and leads to loss of anti-tumor efficacy in mice Erina Koga-YamakawaMasashi MurataChiang J. Li Original Article 20 June 2015 Pages: 1229 - 1239
Sunitinib pretreatment improves tumor-infiltrating lymphocyte expansion by reduction in intratumoral content of myeloid-derived suppressor cells in human renal cell carcinoma Aurelie GuislainJules GadiotChristian U. Blank Original Article 24 June 2015 Pages: 1241 - 1250
A phase I trial combining decitabine/dendritic cell vaccine targeting MAGE-A1, MAGE-A3 and NY-ESO-1 for children with relapsed or therapy-refractory neuroblastoma and sarcoma Deepa K. KrishnadasSuzanne ShustermanKenneth G. Lucas Original Article 24 June 2015 Pages: 1251 - 1260
Expansion of myeloid-derived suppressor cells in chronic obstructive pulmonary disease and lung cancer: potential link between inflammation and cancer Sergio ScriminiJaume PonsJaume Sauleda Original Article 28 June 2015 Pages: 1261 - 1270
Monitoring regulatory T cells in clinical samples: consensus on an essential marker set and gating strategy for regulatory T cell analysis by flow cytometry Saskia J. A. M. SantegoetsEveline M. DijkgraafSjoerd H. van der Burg Original Article Open access 28 June 2015 Pages: 1271 - 1286
Novel strategies for inhibiting PD-1 pathway-mediated immune suppression while simultaneously delivering activating signals to tumor-reactive T cells Suzanne Ostrand-RosenbergLucas A. HornJuan A. Alvarez Focussed Research Review 20 March 2015 Pages: 1287 - 1293
A combined approach of human leukocyte antigen ligandomics and immunogenicity analysis to improve peptide-based cancer immunotherapy Janet Kerstin PeperStefan Stevanović Focussed Research Review 31 March 2015 Pages: 1295 - 1303
Novel metronomic chemotherapy and cancer vaccine combinatorial strategy for hepatocellular carcinoma in a mouse model Maria TagliamonteAnnacarmen PetrizzoLuigi Buonaguro Focussed Research Review 06 May 2015 Pages: 1305 - 1314
Electrochemotherapy of tumors as in situ vaccination boosted by immunogene electrotransfer Gregor SersaJustin TeissieDamijan Miklavcic Focussed Research Review Open access 12 June 2015 Pages: 1315 - 1327
Immunotherapy of HPV-associated cancer: DNA/plant-derived vaccines and new orthotopic mouse models Aldo VenutiGianfranca CurzioFrancesca Paolini Focussed Research Review Open access 03 July 2015 Pages: 1329 - 1338
Targeting tumor vasculature: expanding the potential of DNA cancer vaccines Stefano UgelJohn G. FacciponteAndrea Facciabene Focussed Research Review 13 August 2015 Pages: 1339 - 1348
The Fourteenth International Conference on Progress in Vaccination Against Cancer (PIVAC-14), September 24–26, 2014, Rome, Italy: rethinking anti-tumor vaccines in a new era of cancer immunotherapy Emanuela SignoriFederica Cavallo Meeting Report 12 March 2015 Pages: 1349 - 1356